<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02092441</url>
  </required_header>
  <id_info>
    <org_study_id>BAMC 395266-1</org_study_id>
    <nct_id>NCT02092441</nct_id>
  </id_info>
  <brief_title>Inhalation Intervention for Nausea in the Emergency Department</brief_title>
  <official_title>Inhalation Intervention for Nausea in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized controlled trial comparing inhalation of isopropyl alcohol vs placebo (normal
      saline) pads to treat nausea in emergency department patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is to investigate if inhaling the scent of a typical medical alcohol prep pad will
      alleviate nausea as compared to a identically packaged normal saline prep pad for the
      Emergency Department patient with nausea. The study length will be 10 minutes long. The
      subjects will take several deep nasal inhalations at the 0, 2, 5 minute marks. Level of
      nausea will be recorded during these times and at 10 minutes. The investigators will also
      assess satisfaction of the intervention. As in previous post operative unit studies,the
      hypothesis is that there will a significant difference in levels of nausea between the
      alcohol pad group versus the normal saline pad group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">June 2015</completion_date>
  <primary_completion_date type="Actual">November 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Nausea Verbal Numerical Rating Scale (0-10) at 10 Minutes Post Intervention</measure>
    <time_frame>10 minutes post intervention</time_frame>
    <description>Primary outcome is nausea and vomiting measured on a scale from 0 (&quot;no nausea&quot;) to 10 (&quot;worst nausea imaginable&quot;) Verbal Numerical Response Scale (VNRS) at 10 minutes post intervention.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Verbal Numerical Rating Scale Pain Score (0-10) at 10 Minutes Post Intervention</measure>
    <time_frame>10 minutes post intervention</time_frame>
    <description>Scale ranges from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Satisfaction Measured on a 5-point Likert Scale</measure>
    <time_frame>10 minutes post intervention</time_frame>
    <description>Patient satisfaction of smelling prep pad to alleviate nausea on a scale from 1 (&quot;completely unsatisfied&quot;) to 5 (&quot;completely satisfied&quot;)</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">80</enrollment>
  <condition>Nausea</condition>
  <condition>Vomiting</condition>
  <arm_group>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>isopropyl alcohol prep pad</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>normal saline prep pad</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Alcohol prep pad group</intervention_name>
    <description>Subjects inhale scent of alcohol pad</description>
    <arm_group_label>Alcohol prep pad group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Normal Saline prep pad</intervention_name>
    <description>Subjects inhale scent of placebo (normal saline) pads</description>
    <arm_group_label>Normal Saline prep pad</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age range of 18-65 years of age

          -  complaint of nausea and or vomiting

          -  ability to breathe through nose

          -  ability to read and write English

        Exclusion Criteria:

          -  allergy to isopropyl alcohol

          -  pregnancy or pregnancy status unknown to subject. Pregnancy test only if part of
             clinical course.

          -  recent upper respiratory infection

          -  recent intake of cefoperazone, disulfiram, or metronidazole or any other medications
             that are known produce nausea when exposed to alcohol.

          -  use of antiemetic or psychoactive drug within 24 hours

          -  alcohol abuse

          -  nicotine within last 4 hrs
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kenneth L Beadle, MPAS, BS</last_name>
    <role>Principal Investigator</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Curtis J Hunter, M.D.</last_name>
    <role>Study Director</role>
    <affiliation>BAMC</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Emergency Department, Brooke Army Medical Center</name>
      <address>
        <city>Fort Sam Houston</city>
        <state>Texas</state>
        <zip>78234</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Burleigh-Flayer HD, Gill MW, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner T. Isopropanol 13-week vapor inhalation study in rats and mice with neurotoxicity evaluation in rats. Fundam Appl Toxicol. 1994 Oct;23(3):421-8.</citation>
    <PMID>7835543</PMID>
  </reference>
  <reference>
    <citation>Gill MW, Burleigh-Flayer HD, Strother DE, Masten LW, McKee RH, Tyler TR, Gardiner TH. Isopropanol: acute vapor inhalation neurotoxicity study in rats. J Appl Toxicol. 1995 Mar-Apr;15(2):77-84.</citation>
    <PMID>7782562</PMID>
  </reference>
  <reference>
    <citation>Burleigh-Flayer H, Garman R, Neptun D, Bevan C, Gardiner T, Kapp R, Tyler T, Wright G. Isopropanol vapor inhalation oncogenicity study in Fischer 344 rats and CD-1 mice. Fundam Appl Toxicol. 1997 Apr;36(2):95-111.</citation>
    <PMID>9143479</PMID>
  </reference>
  <reference>
    <citation>Cotton JW, Rowell LR, Hood RR, Pellegrini JE. A comparative analysis of isopropyl alcohol and ondansetron in the treatment of postoperative nausea and vomiting from the hospital setting to the home. AANA J. 2007 Feb;75(1):21-6.</citation>
    <PMID>17304779</PMID>
  </reference>
  <reference>
    <citation>Winston AW, Rinehart RS, Riley GP, Vacchiano CA, Pellegrini JE. Comparison of inhaled isopropyl alcohol and intravenous ondansetron for treatment of postoperative nausea. AANA J. 2003 Apr;71(2):127-32.</citation>
    <PMID>12776641</PMID>
  </reference>
  <reference>
    <citation>Pellegrini J, DeLoge J, Bennett J, Kelly J. Comparison of inhalation of isopropyl alcohol vs promethazine in the treatment of postoperative nausea and vomiting (PONV) in patients identified as at high risk for developing PONV. AANA J. 2009 Aug;77(4):293-9.</citation>
    <PMID>19731848</PMID>
  </reference>
  <reference>
    <citation>Wang SM, Hofstadter MB, Kain ZN. An alternative method to alleviate postoperative nausea and vomiting in children. J Clin Anesth. 1999 May;11(3):231-4.</citation>
    <PMID>10434220</PMID>
  </reference>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2014</study_first_submitted>
  <study_first_submitted_qc>March 19, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 20, 2014</study_first_posted>
  <results_first_submitted>July 3, 2015</results_first_submitted>
  <results_first_submitted_qc>July 3, 2015</results_first_submitted_qc>
  <results_first_posted type="Estimate">July 31, 2015</results_first_posted>
  <last_update_submitted>April 15, 2016</last_update_submitted>
  <last_update_submitted_qc>April 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 23, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brooke Army Medical Center</investigator_affiliation>
    <investigator_full_name>Michael D. April</investigator_full_name>
    <investigator_title>Residency Associate Program Director for Research</investigator_title>
  </responsible_party>
  <keyword>Nausea</keyword>
  <keyword>Vomiting</keyword>
  <keyword>Antiemetic</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Nausea</mesh_term>
    <mesh_term>Vomiting</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
  </intervention_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="P2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="37"/>
                <participants group_id="P2" count="43"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="B2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="37"/>
            <count group_id="B2" value="43"/>
            <count group_id="B3" value="80"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="35.65116" spread="14.17557"/>
                    <measurement group_id="B2" value="31.94595" spread="12.12652"/>
                    <measurement group_id="B3" value="33.9375" spread="13.3154"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="23"/>
                    <measurement group_id="B2" value="33"/>
                    <measurement group_id="B3" value="56"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="10"/>
                    <measurement group_id="B3" value="24"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Nausea Verbal Numerical Rating Scale (0-10) at 10 Minutes Post Intervention</title>
        <description>Primary outcome is nausea and vomiting measured on a scale from 0 (&quot;no nausea&quot;) to 10 (&quot;worst nausea imaginable&quot;) Verbal Numerical Response Scale (VNRS) at 10 minutes post intervention.</description>
        <time_frame>10 minutes post intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alcohol Prep Pad Group</title>
            <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline Prep Pad</title>
            <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
          </group>
        </group_list>
        <measure>
          <title>Nausea Verbal Numerical Rating Scale (0-10) at 10 Minutes Post Intervention</title>
          <description>Primary outcome is nausea and vomiting measured on a scale from 0 (&quot;no nausea&quot;) to 10 (&quot;worst nausea imaginable&quot;) Verbal Numerical Response Scale (VNRS) at 10 minutes post intervention.</description>
          <units>VNRS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3" lower_limit="2" upper_limit="5"/>
                    <measurement group_id="O2" value="6" lower_limit="4.5" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Verbal Numerical Rating Scale Pain Score (0-10) at 10 Minutes Post Intervention</title>
        <description>Scale ranges from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;)</description>
        <time_frame>10 minutes post intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alcohol Prep Pad Group</title>
            <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline Prep Pad</title>
            <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
          </group>
        </group_list>
        <measure>
          <title>Verbal Numerical Rating Scale Pain Score (0-10) at 10 Minutes Post Intervention</title>
          <description>Scale ranges from 0 (&quot;no pain&quot;) to 10 (&quot;worst pain imaginable&quot;)</description>
          <units>VNRS</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="4" upper_limit="7"/>
                    <measurement group_id="O2" value="6" lower_limit="2" upper_limit="7.5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Satisfaction Measured on a 5-point Likert Scale</title>
        <description>Patient satisfaction of smelling prep pad to alleviate nausea on a scale from 1 (&quot;completely unsatisfied&quot;) to 5 (&quot;completely satisfied&quot;)</description>
        <time_frame>10 minutes post intervention</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Alcohol Prep Pad Group</title>
            <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
          </group>
          <group group_id="O2">
            <title>Normal Saline Prep Pad</title>
            <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
          </group>
        </group_list>
        <measure>
          <title>Satisfaction Measured on a 5-point Likert Scale</title>
          <description>Patient satisfaction of smelling prep pad to alleviate nausea on a scale from 1 (&quot;completely unsatisfied&quot;) to 5 (&quot;completely satisfied&quot;)</description>
          <units>5 point Likert Scale</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="37"/>
                <count group_id="O2" value="43"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4" lower_limit="3" upper_limit="5"/>
                    <measurement group_id="O2" value="2" lower_limit="1" upper_limit="3"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>Alcohol Prep Pad Group</title>
          <description>isopropyl alcohol prep pad
Alcohol prep pad group: Subjects inhale scent of alcohol pad</description>
        </group>
        <group group_id="E2">
          <title>Normal Saline Prep Pad</title>
          <description>normal saline prep pad
Normal Saline prep pad: Subjects inhale scent of placebo (normal saline) pads</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="37"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="43"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr. Michael D. April</name_or_title>
      <organization>Brooke Army Medical Center</organization>
      <phone>210-916-6129</phone>
      <email>Michael.D.April@post.harvard.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

